Testing a vaccine to prevent rheumatic heart disease in children
Part of Heart & circulation, Infections clinical trials.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 5 to 8 years old.
- You must live in a study area.
- You must be able to give consent, and your child must be able to agree if required.
- Your child must have no history of rheumatic fever or rheumatic heart disease.
- Your child must not have a heart defect (except a small, harmless one at birth).
- Your child must not have other medical conditions that could make participation unsafe.
- Your child must be able to complete the study follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a program in schools can help prevent rheumatic heart disease in children. If your child is between 5 and 16 years old and attends a participating school, they may be able to join.
This trial tests a vaccine called StreptInCor to see if it's safe and helps the body build immunity against strep bacteria. It may help prevent serious complications like rheumatic fever and heart damage.
This trial tests whether added support helps people stick to their prescribed antibiotics for rheumatic heart disease. It includes adults, children, guardians, community health workers, and healthcare workers.
This study tests whether a prevention program done at a specific school can reduce how common “latent” (hidden) rheumatic heart disease is in children. If you attend the study’s school in Tulsipur, this program may be offered to help protect students’ heart health over time.
This trial tests whether it is safe to stop taking daily penicillin for children and teens whose rheumatic heart disease has improved or stayed mild. If you took part in the GOALIE study and your heart condition is now stable, this study may help determine if you can safely stop medication.
This study tests whether a fun, educational program (with games and activities) can help students in Nepal learn more about rheumatic fever and rheumatic heart disease. If you are in grades 6–9 at a public school, you may be able to join and help see if this approach works.
Hear when a new Rheumatic Heart Disease in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.